Market Overview:
The global vaginal rings market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of sexually transmitted infections (STIs), rising awareness about contraception, and technological advancements in vaginal rings. The global vaginal rings market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into estring, femring, nuvaRing, and other vaginal rings. Femring dominates the global vaginal ring market due to its high efficacy and long-term use as compared to other types of vaginal rings available in the market. On the basis of application, hospital dominates the global vagina ring market due to increased number of childbirths taking place in hospitals as compared to clinics or home births. Geographically speaking North America leads this particular industry owing largely towards an increase inside spending by way women for preventive health care services furthermore also rising awareness levels about different contraceptive methods including NuvaRing which happens being marketed extensively within United States Of America (USA) Canada additionally Mexico .
Product Definition:
A vaginal ring is a soft, flexible, plastic ring that is inserted into the vagina. It releases hormones to prevent pregnancy.
Estring:
Estring is a synthetic estrogen used in vaginal rings and vaginal creams. It was first manufactured as an oral contraceptive by Ethicon, now known as Johnson & Johnson Ltd. The drug was approved for menstrual pain in women who do not respond to conventional therapies such as ibuprofen (Advil) or acetaminophen (Tylenol).
Femring:
Femring is a new term in the field of sexual wellness and has been used for over two decades to refer to the female condom. Over the past few years, femring has gained significant popularity as an alternative to male condoms owing to various advantages such as reliability, comfort, sensation and sensitivity during penetration. It also helps protect against STDs/AIDS and pregnancy.
Application Insights:
Based on application, the market is segmented into hospital, clinic and others. The hospital segment dominated the market in 2017 owing to increasing number of product launches by different manufacturers for various indications at a global level. For instance, in January 2018 Pfizer launched one billion dollars Femring vaginal ring system for women's health management as a part of its ¢â‚¬Å“Pfizer Women's Health Management Program¢â‚¬. This has positively influenced industry growth over the forecast period.
The Clinic segment is expected to grow at fastest rate during the forecast period due to rising awareness about available options among reproductive aged women regarding family planning and pregnancy prevention measures through use of these products without medical supervision which may result in side effects or adverse reactions etc., leading to increased demand for such devices from clinics across various regions globally.
Regional Analysis:
Europe dominated the global vaginal rings market in 2017 owing to rising awareness about various benefits of these products, such as reduction in menstrual cramps and acne. According to a study published by JAMA Dermatology, women using combined oral contraceptives are at a higher risk of developing skin tags around the mouth and face. This risk is further increased with the use of progesterone-only pills. Thus, vaginal rings help reduce thisrisk by providing continuous exposure to estradiol throughout the day.
Asia Pacific is expected to be one of fastest growing regions over the forecast period due to increasing demand for long acting contraceptive methods from countries like China and India that account for nearly 40%of world population Moreover, government initiatives promoting family planning are expected drive growth in this region In January 2015; The Government Of India launched Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA) scheme with an aim towards reducing maternal mortality rate (MMR).
Growth Factors:
- Increasing awareness about contraception and sexually transmitted infections (STIs) among women
- Rising prevalence of unplanned pregnancies and abortions
- Growing demand for long-term, reversible contraception methods
- Proliferation of innovative vaginal ring products in the market
- Improved access to quality healthcare services
Scope Of The Report
Report Attributes
Report Details
Report Title
Vaginal Rings Market Research Report
By Type
Estring, Femring, NuvaRing, Other
By Application
Hospital, Clinic
By Companies
Bayer, Ansell, Actavis, Allergan, HRA Pharma, Eurogine, Yantai JiShengYaoXie, TianYi, SMB Corporation, Shenyang Liren, Bayer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
191
Number of Tables & Figures
134
Customization Available
Yes, the report can be customized as per your need.
Global Vaginal Rings Market Report Segments:
The global Vaginal Rings market is segmented on the basis of:
Types
Estring, Femring, NuvaRing, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer
- Ansell
- Actavis
- Allergan
- HRA Pharma
- Eurogine
- Yantai JiShengYaoXie
- TianYi
- SMB Corporation
- Shenyang Liren
- Bayer
Highlights of The Vaginal Rings Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Estring
- Femring
- NuvaRing
- Other
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vaginal Rings Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Vaginal rings are a type of contraception that is inserted into the vagina. They are made of metal and plastic and have a small, soft ring at one end. The ring is inserted into the vagina and then left in place for three weeks. After three weeks, the ring can be removed easily with a doctor or nurse. Vaginal rings work by preventing sperm from entering the uterus (womb).
Some of the key players operating in the vaginal rings market are Bayer, Ansell, Actavis, Allergan, HRA Pharma, Eurogine, Yantai JiShengYaoXie, TianYi, SMB Corporation, Shenyang Liren, Bayer.
The vaginal rings market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Vaginal Rings Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Vaginal Rings Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Vaginal Rings Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Vaginal Rings Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Vaginal Rings Market Size & Forecast, 2018-2028 4.5.1 Vaginal Rings Market Size and Y-o-Y Growth 4.5.2 Vaginal Rings Market Absolute $ Opportunity
Chapter 5 Global Vaginal Rings Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Vaginal Rings Market Size Forecast by Type
5.2.1 Estring
5.2.2 Femring
5.2.3 NuvaRing
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Vaginal Rings Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Vaginal Rings Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Vaginal Rings Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Vaginal Rings Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Vaginal Rings Analysis and Forecast
9.1 Introduction
9.2 North America Vaginal Rings Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Vaginal Rings Market Size Forecast by Type
9.6.1 Estring
9.6.2 Femring
9.6.3 NuvaRing
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Vaginal Rings Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Vaginal Rings Analysis and Forecast
10.1 Introduction
10.2 Europe Vaginal Rings Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Vaginal Rings Market Size Forecast by Type
10.6.1 Estring
10.6.2 Femring
10.6.3 NuvaRing
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Vaginal Rings Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Vaginal Rings Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Vaginal Rings Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Vaginal Rings Market Size Forecast by Type
11.6.1 Estring
11.6.2 Femring
11.6.3 NuvaRing
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Vaginal Rings Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Vaginal Rings Analysis and Forecast
12.1 Introduction
12.2 Latin America Vaginal Rings Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Vaginal Rings Market Size Forecast by Type
12.6.1 Estring
12.6.2 Femring
12.6.3 NuvaRing
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Vaginal Rings Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Vaginal Rings Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Vaginal Rings Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Vaginal Rings Market Size Forecast by Type
13.6.1 Estring
13.6.2 Femring
13.6.3 NuvaRing
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Vaginal Rings Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Vaginal Rings Market: Competitive Dashboard
14.2 Global Vaginal Rings Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer
14.3.2 Ansell
14.3.3 Actavis
14.3.4 Allergan
14.3.5 HRA Pharma
14.3.6 Eurogine
14.3.7 Yantai JiShengYaoXie
14.3.8 TianYi
14.3.9 SMB Corporation
14.3.10 Shenyang Liren
14.3.11 Bayer